Dogwood Wealth Management LLC
Position in GEHC — GE HealthCare Technologies Inc.
CIK 2056922
LENEXA, KS
Position in GEHC
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$1,024
-$3,460 QoQ
Shares Held
16
-74.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,151
of 1,215 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GEHC Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Dogwood Wealth Management LLC holds $157,221 across 8 Medical Devices names. GEHC ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
903 | $70,641 | |
| 2 | ABT |
Abbott Laboratories
|
611 | $55,442 | |
| 3 | SYK |
Stryker Corp
|
40 | $12,593 | |
| 4 | BSX |
Boston Scientific Corp
|
178 | $7,597 | |
| 5 | EW |
Edwards Lifesciences Corp
|
70 | $6,332 | |
| 6 | DXCM |
Dexcom Inc
|
37 | $2,491 | |
| 7 | TCMD |
Tactile Systems Technology Inc
|
37 | $1,101 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
This page
|
16 | $1,024 |
All Filings in GEHC
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,024 | 16 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $4,484 | 63 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,495 | 67 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $4,130 | 55 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,407 | 73 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $1,372 | 17 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,563 | 20 | Shares | Sole | 2025-03-04 | |
| 2024-09-30 | $1,126 | 12 | Shares | Sole | 2025-02-28 | |
| 2024-06-30 | $935 | 12 | Shares | Sole | 2025-03-04 | |
| 2024-03-31 | $1,090 | 12 | Shares | Sole | 2025-02-28 | |
| 2023-12-31 | $927 | 12 | Shares | Sole | 2025-02-28 | |
| No filing history on record for this holder in this stock. | ||||||